GenMont Biotech Inc (3164) — Cash Flow-to-Debt Ratio
GenMont Biotech Inc (3164) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of NT$15.46 Million could theoretically repay 0% of its total liabilities (NT$297.05 Million) in one year. See how financially flexible is GenMont Biotech Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GenMont Biotech Inc Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for GenMont Biotech Inc across 21 annual periods. For the full cash flow conversion analysis, see cash flow conversion of GenMont Biotech Inc.
Annual Cash Flow-to-Debt Ratio for GenMont Biotech Inc (2005–2025)
Year-by-year debt coverage analysis for GenMont Biotech Inc. Check 3164 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | NT$73.60 Million | NT$215.35 Million | ▼ -36.8% |
| 2024 | 0.54x | NT$123.95 Million | NT$229.06 Million | ▲ +219.1% |
| 2023 | 0.17x | NT$34.60 Million | NT$204.06 Million | ▼ -75.6% |
| 2022 | 0.69x | NT$137.95 Million | NT$198.59 Million | ▲ +8.0% |
| 2021 | 0.64x | NT$111.66 Million | NT$173.65 Million | ▼ -28.8% |
| 2020 | 0.90x | NT$118.27 Million | NT$130.95 Million | ▲ +49.1% |
| 2019 | 0.61x | NT$74.52 Million | NT$123.04 Million | ▲ +3.3% |
| 2018 | 0.59x | NT$56.03 Million | NT$95.60 Million | ▼ -2.2% |
| 2017 | 0.60x | NT$77.56 Million | NT$129.41 Million | ▲ +64.1% |
| 2016 | 0.37x | NT$45.34 Million | NT$124.14 Million | ▲ +1072.6% |
| 2015 | -0.04x | NT$-5.01 Million | NT$133.43 Million | ▲ +91.2% |
| 2014 | -0.43x | NT$-62.00 Million | NT$144.76 Million | ▼ -328.9% |
| 2013 | 0.19x | NT$100.37 Million | NT$536.49 Million | ▲ +549.6% |
| 2012 | -0.04x | NT$-23.58 Million | NT$566.61 Million | ▼ -161.3% |
| 2011 | 0.07x | NT$39.94 Million | NT$588.06 Million | ▼ -78.7% |
| 2010 | 0.32x | NT$200.03 Million | NT$627.66 Million | ▼ -74.0% |
| 2009 | 1.23x | NT$108.53 Million | NT$88.42 Million | ▼ -12.9% |
| 2008 | 1.41x | NT$100.62 Million | NT$71.36 Million | ▲ +53.0% |
| 2007 | 0.92x | NT$43.36 Million | NT$47.04 Million | ▲ +84.5% |
| 2006 | 0.50x | NT$29.56 Million | NT$59.18 Million | ▲ +22.8% |
| 2005 | 0.41x | NT$9.53 Million | NT$23.41 Million | — |